Won B. Kim

500 total citations
32 papers, 461 citations indexed

About

Won B. Kim is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Won B. Kim has authored 32 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 13 papers in Pharmacology and 12 papers in Oncology. Recurrent topics in Won B. Kim's work include Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Won B. Kim is often cited by papers focused on Pharmacogenetics and Drug Metabolism (22 papers), Drug Transport and Resistance Mechanisms (11 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Won B. Kim collaborates with scholars based in South Korea. Won B. Kim's co-authors include Jong Won Kwon, Myung G. Lee, Hyun Joo Shim, So H. Kim, Soo Kyung Bae, Eun Jig Lee, Myung Gyoon Lee, Inchul Lee, Moohi Yoo and Joo H. Lee and has published in prestigious journals such as Nature Biotechnology, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.

In The Last Decade

Won B. Kim

31 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Won B. Kim South Korea 13 249 174 127 94 91 32 461
Martha Sosa‐Macías Mexico 18 315 1.3× 126 0.7× 81 0.6× 43 0.5× 184 2.0× 53 706
Rikard Sandström Sweden 13 201 0.8× 304 1.7× 94 0.7× 49 0.5× 210 2.3× 18 677
Madhusudana R. Chaluvadi United States 6 154 0.6× 173 1.0× 72 0.6× 28 0.3× 71 0.8× 9 430
Wen-Sheng Guo United States 5 218 0.9× 401 2.3× 66 0.5× 37 0.4× 324 3.6× 5 628
Chang-Hong Jiang China 9 179 0.7× 108 0.6× 62 0.5× 30 0.3× 36 0.4× 14 478
Marcos Navares‐Gómez Spain 12 171 0.7× 64 0.4× 49 0.4× 34 0.4× 73 0.8× 35 361
C Zekorn Germany 8 306 1.2× 168 1.0× 48 0.4× 24 0.3× 65 0.7× 10 510
K YU South Korea 4 197 0.8× 248 1.4× 34 0.3× 25 0.3× 154 1.7× 5 395
Rein Seensalu Sweden 14 145 0.6× 157 0.9× 41 0.3× 44 0.5× 43 0.5× 27 864
Dany Chevalier France 15 213 0.9× 106 0.6× 48 0.4× 34 0.4× 109 1.2× 23 589

Countries citing papers authored by Won B. Kim

Since Specialization
Citations

This map shows the geographic impact of Won B. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won B. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won B. Kim more than expected).

Fields of papers citing papers by Won B. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won B. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won B. Kim. The network helps show where Won B. Kim may publish in the future.

Co-authorship network of co-authors of Won B. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Won B. Kim. A scholar is included among the top collaborators of Won B. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won B. Kim. Won B. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Joo H., Soo Kyung Bae, Jong Won Kwon, Won B. Kim, & Myung G. Lee. (2005). Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA‐8159, a new erectogenic, in rats. Biopharmaceutics & Drug Disposition. 26(9). 411–416. 1 indexed citations
2.
Shim, Hyun Joo, et al.. (2005). Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA‐8159, a new erectogenic, in rats. Biopharmaceutics & Drug Disposition. 26(6). 233–241. 21 indexed citations
3.
Kwon, Jong Won, et al.. (2005). Dose‐independent pharmacokinetics of torasemide after intravenous and oral administration to rats. Biopharmaceutics & Drug Disposition. 26(5). 173–182. 13 indexed citations
4.
Bae, Soo Kyung, Jong Won Kwon, Won B. Kim, Inchul Lee, & Myung G. Lee. (2005). Effects of acute renal failure on the pharmacokinetics of DA‐7867, a new oxazolidinone, in rats. Biopharmaceutics & Drug Disposition. 27(1). 29–37. 2 indexed citations
5.
Shim, Hyun Joo, et al.. (2005). Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans. Biopharmaceutics & Drug Disposition. 26(4). 161–166. 8 indexed citations
6.
Bae, Soo Kyung, et al.. (2004). Pharmacokinetics, blood partition and protein binding of DA‐7867, a new oxazolidinone. Biopharmaceutics & Drug Disposition. 25(3). 127–135. 14 indexed citations
7.
Shim, Hyun Joo, et al.. (2004). Pharmacokinetic changes of DA‐8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate. Biopharmaceutics & Drug Disposition. 25(3). 137–142. 3 indexed citations
8.
Bae, Soo Kyung, et al.. (2004). Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats. Journal of Pharmaceutical Sciences. 93(9). 2364–2373. 8 indexed citations
9.
Kwon, Jong Won, et al.. (2004). Pharmacokinetic changes of DA‐8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin. Journal of Pharmaceutical Sciences. 93(9). 2374–2387. 9 indexed citations
10.
Lee, Joo H., et al.. (2004). Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate. Biopharmaceutics & Drug Disposition. 25(6). 273–282. 24 indexed citations
11.
Shim, Hyun Joo, et al.. (2003). Pharmacokinetics of DA‐8159, a New Erectogenic, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First‐Pass Effects. Journal of Pharmaceutical Sciences. 92(11). 2185–2195. 39 indexed citations
12.
Lee, Inchul, et al.. (2003). Effects of Glucose on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats with Acute Renal Failure Induced by Uranyl Nitrate. Journal of Pharmaceutical Sciences. 92(8). 1604–1613. 18 indexed citations
13.
Shim, Hyun Joo, Dong Kim, Kyung Koo Kang, et al.. (2003). Subacute toxicities and toxicokinetics of DA‐8159, a new phosphodiesterase type V inhibitor, after single and 4‐Week repeated oral administration in rats. Biopharmaceutics & Drug Disposition. 24(9). 409–418. 8 indexed citations
14.
Ha, Sang‐Jun, Jun Chang, Man Ki Song, et al.. (2002). Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization. Nature Biotechnology. 20(4). 381–386. 51 indexed citations
15.
Shim, Hyun Joo, Eun Jig Lee, Moohi Yoo, et al.. (2000). Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA‐8159, using an equilibrium dialysis technique. Biopharmaceutics & Drug Disposition. 21(7). 285–291. 64 indexed citations
16.
Kim, So H., Won B. Kim, Jong Won Kwon, & Myung G. Lee. (1999). Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits. Biopharmaceutics & Drug Disposition. 20(3). 125–129. 8 indexed citations
17.
18.
Kim, So H., Jong Won Kwon, Won B. Kim, & Myung G. Lee. (1999). Effects of Cilastatin on the Pharmacokinetics of a New Carbapenem, DA-1131, in Rats, Rabbits, and Dogs. Antimicrobial Agents and Chemotherapy. 43(10). 2524–2527. 6 indexed citations
19.
Kim, So H., Won B. Kim, & Myung G. Lee. (1999). Effect of Probenecid on the Renal Excretion Mechanism of a New Carbapenem, DA-1131, in Rats and Rabbits. Antimicrobial Agents and Chemotherapy. 43(1). 96–99. 7 indexed citations
20.
Kim, So H., Won B. Kim, & Myung G. Lee. (1998). Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus. Biopharmaceutics & Drug Disposition. 19(5). 303–308. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martha Sosa‐Macías Breakdown of academic impact, for papers by Rikard Sandström Breakdown of academic impact, for papers by Madhusudana R. Chaluvadi Breakdown of academic impact, for papers by Wen-Sheng Guo Breakdown of academic impact, for papers by Chang-Hong Jiang Breakdown of academic impact, for papers by Marcos Navares‐Gómez Breakdown of academic impact, for papers by C Zekorn Breakdown of academic impact, for papers by K YU Breakdown of academic impact, for papers by Rein Seensalu Breakdown of academic impact, for papers by Dany Chevalier
Rankless by CCL
2026